Ranking
The High-Tech & Technology Department at Lipa Meir & Co. specializes in providing legal advice, representation and guidance to private and publicly traded High-Tech companies from the various technology fields, including internet, software, hardware, bio-tech, medical devices, energy, clean-tech, communication, semi-conductors, and technology integration. The department provides a vast array of services to a wide range of High-Tech companies. Such services include advising and representing start-ups at all stages of their life cycle, from formation, through M&A and beyond. The department represents mature High-Tech companies, publicly traded companies and investors, in their ongoing commercial activities and in transactions in Israel and abroad.
The attorneys of the High-Tech & Technology Department at Lipa Meir have a technological background (such as from the IDF, work in High-Tech companies and academia), have undergone specialized training, and have extensive experience in the representation of the diverse portfolio handled by the department. Such representation includes, among others:
Formation of corporations, founders agreements, employee and labor relations agreements, executive compensation plans and employee benefit plans, consulting agreements, option plans (ESOP), lease agreements, confidentiality, non-disclosure and non-compete agreements, agreements with vendors and voluntary liquidation.
Financing Transactions – representing companies, venture capital funds and angels in investment rounds, private equity transactions and M&A transactions.
Securing Grants – representation in the interaction with the Israeli Chief Scientist and other grant programs, including international grant programs.
Technology & Intellectual Property Transactions – licensing agreements, R&D, teaming and JV, strategic partnerships agreements including the issues of ownership/licensing of resulting IP, databases, Big Data, Business Intelligence, privacy issues, OEM agreements, marketing, distribution, VAR, support & maintenance agreements and more.
The Health Field – the department represents suppliers and customers in the fields of medical devices, Pharmaceuticals and biotechnology. Such representation includes advising through clinical and other trials, R&D and IP collaborations with medical institutions, universities and research centers, manufacturing agreements, distribution agreements, IP commercialization and more.
The IT Field – the department provides legal counsel to vendors and customers, including formulating unique industry oriented agreements, which reflect the added value of the department in technological aspects. The department represents and advises clients and vendors in the acquisition and integration of highly complex IT system projects, including CRM, ERP, Billing and others, from a wide range of suppliers, such as MS -AX, SAP and Oracle. The representation includes handling the proceedings for selecting a vendor, such as tender or similar processes. These may include drafting RFI, RFP or tender documents, evaluating proposals, best & final, taking an active part in negotiations until finalization of the transaction, and thereafter in its performance as necessary.
The combination of the technological know-how, business sense, legal knowledge and experience, enables the department to provide its clients with a unique, added-value service tailored to their needs while “thinking outside the box” and always in compliance with the local legal requirements.
Our firm is professionally recognized in the hi-tech practice by both Israeli and international ranking guides.
News & Publications
30.08.24
A new law governing the collection, retention and use of biometric data from tourists and visitors
Newsletter
The Israeli parliament (the “Knesset”) has recently passed the Law for obtaining Biometric Identification Means from Foreigners, Production of Biometric Identification Data and a Database, 2024 (the “Law”), thus joining the US, the EU and other countries who have already adopted substantially similar measures. The Law will enter into force upon the earlier of the […]
19.04.24
Reflections on Gamified Technology in the Mental Health Sector
THE US-ISRAEL LEGAL REVIEW 2023
Imagine a world where healthcare delivery is seamlessly woven into immersive virtual realities, where patients embark on engaging personalized quests to conquer their mental health struggles. This vision materializes as gamification, the art of integrating game-like elements into non-game settings, is captivating the healthcare industry. With a surge in investments and research dedicated to exploring the […]
29.01.24
The European Commission reconfirms Israel’s adequacy status regarding privacy and data protection
Newsletter
On January 15, 2024 the EU Commission has issued a “REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the first review of the functioning of the adequacy decisions adopted pursuant to Article 25(6) of Directive 95/46/EC” (the “Report”). The Report includes the EU Commission’s decision to reconfirm Israel’s adequacy in relation […]
15.06.23
How new heavyweight players impact the traditional healthcare arena?
International Bar Association - IBA
We are honored to have taken an active part in the 9th conference of the International Bar Association held in Washington, focused on health and life sciences. Gary Copelovitz, who co-heads our Technology and M&A department, and heads our vibrant Life Sciences practice, moderated a round table on the new heavyweight players in the healthcare […]
30.05.23
Taxation of SAFEs Investments – New Israeli Tax Authority Guidance Newsletter May 29, 2023
On May 16, 2023, the Israeli Tax Authority issued guidance regarding the taxation of investments in companies through Simple Agreement for Future Equity (i.e., SAFE). SAFE instrument was introduced as an alternative to traditional investment or convertible loan for early-stage investments in startups. SAFEs offer simplicity, efficiency and cost-effectiveness and enable the startup companies to […]
14.04.23
?Will Israel’s Hi-Tech sector be recognizable by 2024
The Jerusalem Post
In an article in the Jerusalem Post, Amir Zolty, partner and head of our Hi-Tech practice, notes that quite a few companies are already laying the ground for relocation, given the looming legislation – intended to strengthen the executive branch and to restrict judicial review. Amir speaks mainly about two trends: incorporating most (some say – […]
01.01.23
Desert Tech as the Next Investment Opportunity – and Israel’s High Tech Contribution
The US-Israel Legal Review
Desert Tech: Dr. Ziv Preis, co-head of the firm’s Technology, Corporate and M&A Department, together with Adv. Natalie Shva, have explored the investment opportunities in Desert Tech in an article in The US-Israel Legal Review. Read the full article
04.12.22
Israel’s new government: Will innovation, science, and technology be put on the back burner?
Geektime Mgazin
What should the new government do to help the local tech industry? Geektime presented this question to senior experts from the hi-tech industry in a special feature for Geektime magazine. According to Amir Zolty, partner and our Head of the Hi-Tech practice: “ leave the internal perimeter to the industry and professionals and use the governmental […]
16.11.22
Foresight Signs Commercial Agreement With SUNWAY-AI
GlobeNewswire
Congratulations to our client, Foresight Automotive, traded on TASE and NASDAQ, on a landmark transaction with Chinese SUNWAY-AI for development and supply of obstacle detection systems. Foresight was advised by Gregory Irgo, partner. To read click here
13.11.22
Clalit Health Services entering a strategic partnership with IQVIA, the largest CRO in the world
clinicaltrialsarena.com
Congratulations Clalit Health Services on entering a strategic partnership with IQVIA, the largest CRO in the world, to open its first PRIME SITE in Israel. The alliance is expected to merge the respective expertises of IQVIA and Clalit in clinical trial delivery, real-world research and genomics, thereby establishing a unique and innovative platform for the advancement of […]
06.10.22
A Year of Crisis in Israeli High Tech
Geektime
Read an article on A Year of Crisis in Israeli High Tech as an Opportunity for Better Future, which was written by Dr. Ziv Preis, partner and co-head of our Technology. Corporate, and Mergers & Acquisitions Department. The article addresses the strength of the Israeli high-tech, the challenges and the call for opportunity. The full […]
01.09.22
Israel: Breathing More Life into Life Sciences
Israel Desks
It was a privilege to contribute to a national exploration of trends affecting the Israeli life sciences sector, carried out by Israel Desks magazine. “Med-tech is here to stay,” pointed out Gary Copelovitz, partner and co-head of our Technology, Corporate and M&A Department, also stating that VC funds are “looking to continue challenging and disrupting […]
26.08.22
Israel’s unicorn success story boosts optimism
Israel Desks
It was an honor to have two of our partners share their thoughts with the Legal Business feature: Israel’s unicorn success boosts optimism. While Dr. Ziv Preis discussed expectations of strong sectors, such as AgriTech, FoodTech, Telehealth, and applied artificial intelligence, Amir Zolty added: “VCs and CVCs keep investing in promising start-ups with strong teams, be it at lower/more […]
26.08.22
Towards better corporate governance of publicly traded companies with no controlling shareholder(s) – The current situation in Israel and the outstanding bill
Legal Business
We are proud to have contributed our insights to a feature in Legal Business examining shareholder activism in publicly traded companies in Israel. While such companies have typically been controlled by a single shareholder or a group of shareholders acting together, legislation and ongoing privatization of governmental companies have led to an increase in the […]
16.06.22
Clalit Health Services and Lynx MD Announce Partnership to Drive Cloud-based Medical Research
CISION PR NEWSWIRE
Congratulations to Clalit Health Services on its agreement with Israeli start-up Lynx (Lynx.MD), regarding a unique research venture that uses cloud-based technology. Clalit will benefit from cutting-edge technology that will allow for research based on de-identified data, and enable researchers to develop innovative treatments, as well as smart and accurate medical solutions. Clalit was represented […]
04.06.22
14.04.22
Digital Health In Israel – The Upsurge Of Big Data & Preemptive Medicine: The Role Of The Public Sector
US Israel Legal Review
In this era of massive global interest in the potential of AI and digital health, investments in the digital health field exceeded $20 billion in less than a six-month period in 2021 alone. The future of this sector is seen by many experts to hinge on utilizing and mastering Big Data and AI capabilities for algorithmic […]
14.04.22
Privacy under attack – one more consequence of long COVID
US Israel Legal Review
The COVID pandemic has challenged many basic notions of privacy and human freedoms since March 2020. While certain rulings of the Israeli Supreme Court may be encouraging, the overall privacy situation is still under constant attack. Read the insights of Amir Zolty, Partner in the latest US Israel Legal Review For the full publication click […]
12.09.21
E-signature World Guide
Ally Law
As an international organization comprising more than 70 law firms worldwide, Ally Law has worked with its member firms to put together a valuable guide on the regulation of e-signatures and digital transactions around the world. Gary Copelovitz, Head of our International Department, provided the relevant information on the applicable regulation in Israel, which you […]
05.09.21
We asked: ‘What was the biggest moment for you this year?’
CALCALIST
CTech Magazine asked 19 tech leaders across the country to answer one question: ‘What was the biggest moment for you this year?’ Amir Zolty, partner and Head of Hi-Tech Practice at our firms: “It was the best of times (for Big Data), it was the worst of times (for the rest). Covid-19 has served as […]
20.05.21
Life Sciences Lawyer of the Year
LMG Life Sciences Awards
Lipa Meir & Co. is hugely proud and would like to congratulate our partner and Head of International Department, Gary Copelovitz, who has won “Corporate Lawyer of the Year” at this year’s LMG’s Life Sciences Legal Awards in Europe. LMG Life Sciences Awards Researcher John Harrison said of Gary’s win: “He is well-known for his […]
23.02.21
Virtual Cyber Mission 2.0
British Embassy in Israel
In today’s digital world, the growth in technology exposes companies to cyber threats. Lipa Meir, among the leading Israeli law firms in cyber, is proud to take part in a unique initiative, organized by the British Embassy in Israel and the Europe Israel Economic & Innovation Forum (EIEI), exploring business and Investment opportunities in the […]
19.10.20
Mileutis raises $20 million to reduce antibiotic use in cows
Calcalistech
Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment […]
13.08.20
For the First Time, EU Sanctions in Response to Cyberattacks: Enhanced Deterrence Efforts by Western Countries?
INSS
The European Union announced restrictive measures against individuals and entities from China, North Korea, and Russia. The move, the first of its kind, indicates increasing cooperation among Western countries, intended to relay a deterrent message to potential attackers – and prevent future cyberattacks. On July 30, 2020, the European Union decided to impose restrictive measures […]
21.07.20
FutureMed 2020 – Online Conference
FutureMed 2020
The first wave of the CoronaVirus pandemic has hit every sphere of public and private life. Different governments have presented different approaches, all of which have been asked to plan and adopt health management and new regulations on the move, while no one has an unequivocal answer to the key question: What is the right […]
16.04.20
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
25.02.20
You Exercised Your 102 Options to Shares As An Employee – You’re Not Necessarily a Shareholder
Newsletter
An employee exercising options to company’s shares is not necessarily a shareholder with shareholders rights as long as those shares are held by the trustee According to a recent decision in the Haifa District Court – Civil Case 19042-03-18 Navon vs. Sol Chip Ltd. – an employee has been granted options to purchase shares of […]
02.01.20
Singapore a Perfect Place for Fundraising and IPO’s
Singapore is well known as a regional hub, as far as capital markets, business activities, and research and development are concerned. Among other things – thanks to its geopolitical positioning, its thriving economy and its business-friendly and efficient approach. Moreover, the close relations between the states, as well as their common “British” origins (and the […]
05.05.19
Water Technology in Brazil
IsraelDesks
The relationship between Brazil and Israel, in the techno-cultural arena, is heating up. Dr. Ziv Preis, Heads Cross Border Mergers & Acquisitions, Banking & Finance Department, on the challenges and opportunities for water and agriculture on page 10. to read more please click here